AI assistant
Sending…
MARZETTI CO — Director's Dealing 2006
Feb 8, 2006
31063_dirs_2006-02-08_939575cf-ff7a-493f-8c59-bc90973b9dc8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANCASTER COLONY CORP (LANC)
CIK: 0000057515
Period of Report: 2006-02-07
Reporting Person: BOYLAN JOHN L (Director, Vice President & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-02-07 | Common Stock-Employee Stock Option (Right to Buy) | M | 15000 | $29.50 | Acquired | 18366 | Direct |
| 2006-02-07 | Common Stock | S | 14000 | $41.5673 | Disposed | 4366 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2001-02-28 | Common Stock - Employee Stock Option (Right to Buy) | $29.50 | M | 15000 | Acquired | 2006-03-31 | Common Stock (15000) | Direct |
| 2001-02-28 | Common Stock - Employee Stock Option (Right to Buy) | $29.50 | M | 15000 | Disposed | 2006-03-31 | Common Stock (15000) | Direct |
| 2003-02-26 | Common Stock - Employee Stock Option (Right to Buy) | $37.23 | M | 15000 | Acquired | 2008-03-31 | Common Stock (15000) | Direct |
| 2005-02-23 | Common Stock - Employee Stock Option (Right to Buy) | $41.52 | M | 15000 | Acquired | 2010-02-28 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 306.525 | Indirect |
| Common Stock | 5283.2115 | Indirect |
Footnotes
F1: Shares contributed by Lancaster Colony Corporation as a matching contribution under Lancaster Colony Corporation's 401(k) Plan as of 6/30/05.
F2: Reflects ESOP allocations that had occurred as of 6/30/05.
More from MARZETTI CO
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 11
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2026
Jan 7
Director's Dealing
2025
Nov 24